Top Stories
-
Fewer than 1 in 10 patients with glioblastoma—the most common type of brain cancer—respond to immunotherapy; a new study reveals how to detect patients who may respond.
Topic
-
A multicenter study from SWOG Cancer Research Network found that infections with hepatitis B and C are common in new cancer patients, but few of these patients are screened for the viruses.
Topic
-
In a phase three clinical trial, sorafenib stopped progression of desmoid tumors for two years in 80 percent of patients who completed treatment.
-
Anil K. Rustgi, MD, an expert in gastrointestinal tumors, will join Columbia University Irving Medical Center and NewYork-Presbyterian as director of the Herbert Irving Comprehensive Cancer Center.
Latest News
- July 8, 2016
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
Topic
- July 1, 2016
CUMC, NYP, and Weill Cornell are participating in a care delivery model that supports and encourages higher quality, more coordinated cancer care.
Topic
-
Source:
New York TimesJune 23, 2016 - June 22, 2016
New research suggests that direct transmission of cancer among marine animals may be much more common than once thought.
Topic
- June 22, 2016
Cancer centers announce the establishment of a research consortium focused on accelerating the discovery and development of novel cancer therapeutics and diagnostics for the benefit of patients.
- June 16, 2016
One out of four breast cancer patients skipped hormonal therapy if they previously avoided treating chronic conditions, Columbia researchers found.
Topic
- March 31, 2016
An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA levels who had more aggressive disease.
Topic
- February 8, 2016
A Super Bowl ad has launched a new campaign at NewYork-Presbyterian Hospital that showcases Columbia and Weill Cornell expertise in cancer, particularly immunotherapy.
- January 28, 2016
A comprehensive analysis of the molecular characteristics of gliomas—the most common malignant brain tumor—explains why some patients diagnosed with slow-growing (low-grade) tumors quickly succumb to the disease while others with more aggressive (high-grade) tumors survive for many years.
Topic
- January 27, 2016
NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine are among the nation’s top cancer centers calling for increased human papillomavirus (HPV) vaccination for the prevention of cancer.
Topic
